表达传染性法氏囊病病毒VP2蛋白的重组复制缺陷型HAdV-5的构建及鉴定

doi:10.16431/j.cnki.1671-7236.2022.12.002

摘要/Abstract

摘要： 【目的】采用AdEasy系统构建能表达传染性法氏囊病病毒（Infectious bursal disease virus，IBDV） VP2蛋白的重组复制缺陷型人5型腺病毒（Human adenovirus serotype-5，HAdV-5），以期为IBDV活载体疫苗的研发提供新的思路。【方法】通过同源重组将VP2基因克隆至穿梭质粒pAdTrack-GOI构建重组穿梭质粒pAdTrack-VP2；PmeⅠ酶线性化pAdTrack-VP2后热击转化大肠杆菌BJ5183-AD-1感受态细胞，利用菌内同源重组构建重组腺病毒质粒pAd-VP2；将pAd-VP2经PacⅠ酶线性化和纯化后转染HEK293A细胞，包装表达VP2蛋白的重组复制缺陷型HAdV-5（rAd5-VP2），将鉴定正确的重组病毒感染非复制型细胞（Vero、CEF和DF1细胞）并分析目的蛋白的表达情况。【结果】将rAd5-VP2通过HEK293A细胞扩大培养，测得第10代病毒的滴度为7.9×10⁹ IFU/mL；RT-PCR结果显示，VP2基因在重组腺病毒中能稳定翻译；Western blotting和间接免疫荧光试验均检测到VP2蛋白的表达，蛋白分子质量为41 ku；将rAd5-VP2感染Vero、CEF和DF1细胞也检测到VP2蛋白的表达，表明HAdV-5有作为IBDV活载体疫苗研发的可能性。【结论】本研究构建了重组复制缺陷型HAdV-5，该毒株能感染部分哺乳动物细胞和家禽细胞并能检测到目的蛋白的表达。

关键词: 传染性法氏囊病; VP2蛋白; 重组复制缺陷型人5型腺病毒

Abstract: 【Objective】 The purpose of this study was to construct recombinant replication-deficient Human adenovirus serotype-5 (HAdV-5), that could express the VP2 protein of Infectious bursal disease virus (IBDV) by using the AdEasy system, in order to provide a new idea for the development of IBDV live vector vaccine.【Method】 By homologous recombination, VP2 gene was cloned into the shuttle plasmid pAdTrack-GOI, and finally the recombinant shuttle plasmid named pAdTrack-VP2 was constructed.After linearization of pAdTrack-VP2 by PmeⅠ enzyme, it was transformed into E.coli BJ5183-AD-1 competent cells by heat shock.The recombinant Adenovirus plasmid named pAd-VP2 was constructed by homologous recombination in bacteria.After that, pAd-VP2 was digested with PacⅠ enzyme, and the purified product was transfected into HEK293A cells to package the recombinant replication-deficient HAdV-5 (rAd5-VP2) expressing VP2 protein.The identified recombinant viruses were infected with non-replicating cells such as Vero cells, CEF cells and DF1 cells, and the expression of the target protein was analyzed.【Result】 rAd5-VP2 was expanded by HEK293A cells and the titer of the 10th generation Adenovirus was 7.9×10⁹ IFU/mL.RT-PCR showed that VP2 gene could translate stably in recombinant Adenovirus.Both Western blotting and indirect immunofluorescence assays detected the expression of VP2 protein with a molecular weight of 41 ku.The expression of VP2 protein was also detected in Vero cells, CEF cells and DF1 cells infected with recombinant Adenovirus, indicating that HAdV-5 has the potential to be developed as a live vector vaccine for IBDV.【Conclusion】 Recombinant replication-deficient HAdV-5 was constructed, which could infect some mammalian cells and poultry cells, and the expression of the target protein could be detected.

Key words: infectious bursal disease; VP2 protein; recombinant replication-deficient Human adenovirus serotype-5

中图分类号:

S852.65^＋7

徐婷, 熊挺, 李淋雨, 刘郁夫, 温良海, 谢文婷, 杨泽坤, 陈瑞爱. 表达传染性法氏囊病病毒VP2蛋白的重组复制缺陷型HAdV-5的构建及鉴定[J]. 中国畜牧兽医, 2022, 49(12): 4524-4534.

XU Ting, XIONG Ting, LI Linyu, LIU Yufu, WEN Lianghai, XIE Wenting, YANG Zekun, CHEN Ruiai. Construction and Identification of Recombinant Replication-deficient HAdV-5 Expressing VP2 Protein of Infectious Bursal Disease Virus[J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(12): 4524-4534.

参考文献

[1] LI J, ZHENG S J.Role of microRNAs in host defense against Infectious bursal disease virus (IBDV) infection:A hidden front line[J].Viruses, 2020, 12(5):543.
[2] INGRAO F, RAUW F, LAMBRECHT B, et al.Infectious bursal disease:A complex host-pathogen interaction[J].Developmental and Comparative Immunology, 2013, 41(3):429-438.
[3] 沈思思, 陈亮, 冯万宇, 等.鸡传染性法氏囊病诊断与防治[J].家禽科学, 2022, 44(4):63. SHEN S S, CHEN L, FENG W Y, et al.Diagnosis and control of infectious bursal disease in chicken[J].Poultry Science, 2022, 44(4):63.(in Chinese)
[4] 韩坤, 王霞.鸡传染性法氏囊病的临床特点与防治措施[J].中国动物保健, 2022, 24(5):65-66. HAN K, WANG X.Clinical characteristics and control measures of infectious bursal disease in chickens[J].China Animal Health, 2022, 24(5):65-66.(in Chinese)
[5] QIAO Q, SONG M, SONG C, et al.Single-dose vaccination of recombinant chimeric Newcastle disease virus (NDV) LaSota vaccine strain expressing Infectious bursal disease virus (IBDV) VP2 gene provides full protection against genotype Ⅶ NDV and IBDV challenge[J].Vaccines (Basel), 2021, 9(12):1483.
[6] SPIES U, MVLLER H, BECHT H.Nucleotide sequence of Infectious bursal disease virus genome segment A delineates two major open reading frames[J].Nucleic Acids Research, 1989, 17(19):7982.
[7] LEE M S, DOONG S R, LAI S Y, et al.Processing of Infectious bursal disease virus (IBDV) polyprotein and self-assembly of IBDV-like particles in Hi-5 cells[J].Biotechnology Progress, 2006, 22(3):763-769.
[8] OÑA A, A, LUQUE D, ABAITUA F, et al.The C-terminal domain of the pVP2 precursor is essential for the interaction between VP2 and VP3, the capsid polypeptides of Infectious bursal disease virus[J].Virology, 2004, 322(1):135-142.
[9] 范林进.鸡传染性法氏囊病病毒新型变异株的鉴定及疫苗株构建[D].北京:中国农业科学院, 2020. FAN L J.Identification and vaccine strain construction of the novel variant Infectious bursal disease virus[D].Beijing:Chinese Academy of Agricultural Sciences, 2020.(in Chinese)
[10] BOOT H J, TER HUURNE A A, HOEKMAN A J, et al.Rescue of very virulent and mosaic Infectious bursal disease virus from cloned cDNA:VP2 is not the sole determinant of the very virulent phenotype[J].Journal of Virology, 2000, 74(15):6701-6711.
[11] LETZEL T, COULIBALY F, REY F A, et al.Molecular and structural bases for the antigenicity of VP2 of Infectious bursal disease virus[J].Journal of Virology, 2007, 81(23):12827-12835.
[12] GUO X, SUN W, WEI L, et al.Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for Infectious bursal disease virus[J].Transboundary and Emerging Diseases, 2021, 68(6):3658-3675.
[13] ZHU F C, WURIE A H, HOU L H, et al.Safety and immunogenicity of a recombinant Adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone:A single-centre, randomised, double-blind, placebo-controlled, phase 2 trial[J].Lancet, 2017, 389(10069):621-628.
[14] 杜倩茹, 王楠楠, 任广彩, 等.表达IBDV VP2蛋白的基因Ⅶ型重组新城疫病毒的构建及鉴定[J].中国兽医学报, 2021, 41(8):1464-1469. DU Q R, WANG N N, REN G C, et al.Construction and identification of recombinant genotype Ⅶ Newcastle disease virus expressing VP2 protein of Infectious bursal disease virus[J].Chinese Journal of Veterinary Science, 2021, 41(8):1464-1469.(in Chinese)
[15] MAHGOUB H A, BAILEY M, KAISER P.An overview of infectious bursal disease[J].Archives of Virology, 2012, 157(11):2047-2057.
[16] WANG Y S, WANG Z C, TANG Y D, et al.Comparison of four Infectious bursal disease viruses isolated from different bird species[J].Archives of Virology, 2007, 152(10):1787-1797.
[17] 何献铭, 任广彩, 叶俊贤, 等.1株传染性法氏囊病病毒的分离鉴定及VP2基因序列分析[J].中国畜牧兽医, 2022, 49(3):1005-1014. HE X M, REN G C, YE J X, et al.Isolation and identification of a strain of Infectious bursal disease virus and sequence analysis of VP2 gene[J]. China Animal Husbandry & Veterinary Medicine, 2022, 49(3):1005-1014.(in Chinese)
[18] 王彦伟, 张素玲, 吴芃, 等.鸡传染性法氏囊病病毒rVP2蛋白高效组装亚病毒颗粒的鉴定[J].中国畜牧兽医, 2020, 47(6):1677-1684. WANG Y W, ZHANG S L, WU P, et al.Identification of subviral particles efficiently self-assembled by Infectious bursal disease virus rVP2 protein[J]. China Animal Husbandry & Veterinary Medicine, 2020, 47(6):1677-1684.(in Chinese)
[19] BOUDAOUD A, MAMACHE B, TOMBARI W, et al.Virus mutations and their impact on vaccination against infectious bursal disease (Gumboro disease)[J].Revue Scientifique et Technique, 2016, 35(3):875-897.
[20] 祁小乐, 高立, 王笑梅.传染性法氏囊病病毒的自然重组[J].微生物学报, 2016, 56(5):740-746. QI X L, GAO L, WANG X M.Naturally occurring reassortants of Infectious bursal disease virus-A review[J].Acta Microbiologica Sinica, 2016, 56(5):740-746.(in Chinese)
[21] FAN L, WU T, HUSSAIN A, et al.Novel variant strains of Infectious bursal disease virus isolated in China[J].Veterinary Microbiology, 2019, 44(230):212-220.
[22] 朱艳平, 何勇, 刘佳, 等.鸡传染性法氏囊病病毒VP2蛋白与幽门螺杆菌铁蛋白基因融合PCR扩增及其真核表达载体的构建[J].中国畜牧兽医, 2019, 46(10):2860-2866. ZHU Y P, HE Y, LIU J, et al.Fusion PCR of chicken Infectious bursal disease virus VP2 and Helicobacter pylori ferritin fusion gene and construction of its eukaryotic expression vector[J]. China Animal Husbandry & Veterinary Medicine, 2019, 46(10):2860-2866.(in Chinese)
[23] YANG D, ZHANG L, DUAN J, et al.A single vaccination of IBDV subviral particles generated by Kluyveromyces marxianus efficiently protects chickens against novel variant and classical IBDV strains[J].Vaccines (Basel), 2021, 9(12):1443.
[24] MARUSIC C, DRISSI TOUZANI C, BORTOLAMI A, et al.The expression in plants of an engineered VP2 protein of Infectious bursal disease virus induces formation of structurally heterogeneous particles that protect from a very virulent viral strain[J].Public Library of Science One, 2021, 16(2):e0247134.
[25] SHEPPARD M, WERNER W, TSATAS E, et al.Fowl adenovirus recombinant expressing VP2 of Infectious bursal disease virus induces protective immunity against bursal disease[J].Archives of Virology, 1998, 143(5):915-930.
[26] HASSAN A O, AMEN O, SAYEDAHMED E E, et al.Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 Avian influenza viruses[J].Public Library of Science One, 2017, 12(10):e0186244.
[27] TANG J, YIN D, WANG R, et al.A recombinant Adenovirus expressing the E protein of Duck Tembusu virus induces protective immunity in duck[J].The Journal of Veterinary Medical Science, 2019, 81(2):314-320.
[28] LI D, DU Q, WU B, et al.Immunogenicity of Adenovirus vaccines expressing the PCV2 capsid protein in pigs[J].Vaccine, 2017, 35(36):4722-4729.